Clinical Trial Update: Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tiotropium bromide inhalation solution in subjects with chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• tiotropium bromide inhalation solution (tiotropium bromide inhalation solution)

Snippet

Sponsor: Nephron Pharmaceuticals Corporation | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED